However, clinical trials with atacicept blocking BAFF and APRIL, cytokines important in B cell survival and function, increased disease activity in MS, demonstrating that some B cell subsets have anti-inflammatory functions [10]. The gene discussed is TNFSF13B; the disease is myeloid sarcoma.